1. Introduction
Wound healing is a complex and coordinated process that involves different kind of cells and molecular signaling. The main objective of this process is to restore physiological and esthetical proprieties. The last step involves the collagen type III substitution by collagen type I and the reordered of both type of fibers to improve the mechanical proprieties. Injures remain as a clinical problem due early and late complications, otherwise the incidence of chronic wounds has rapidly increased due to the rising prevalence of type 2 diabetes, peripheral vascular disease, and metabolic syndrome [
1,
2,
3].
Even though, fast and optimal wound closure are the main aims for wound care, no topically effective medication has been developed to accelerate the wound healing process and/or to prevent abnormal wound healing [
4].
Wound healing effects of phenolic compounds such as flavonoids, secoriridoids, phenolic acids, phenolic alcohols and lignans have been studied, due their antioxidant, antimicrobial, and/or bio-stimulatory properties related to tissue regeneration [
5].
Bacopa procumbens has been used in traditional medicine to skin wound healing, their polyphenolic compounds (BP) regulated proliferation and cell adhesion; and enhanced migration in
in vitro assays; in rat model BP accelerates wound healing process at least 48 h, reducing inflammation, increasing cell proliferation, promoting the deposition and organization of collagen by regulating the canonical and no canonical TGF-β1 expression pathways [
6].
Nanoformulation has been successful in transporting, protecting, and delivering active drugs, to obtain synergistic and/or enhanced response at the bio-interface [
4,
7]. Particularly, due to their unique physical chemical properties, and biocompatibility, gold nanoparticles (AuNPs) have been used in a broad range of applications comprising genomics, biosensors, immune-analysis, clinical chemistry, diagnosis, and pharmaceutics, conferring to biomolecules diverse proprieties such as deliver, stabilization and reduction of adverse effects of drugs or plant extracts [
8].
AuNPs could be synthesized by the Au (III) reduction through a simple and reproducible method proposed by Turkevich, using citrate reduction [
9].
Surface plasmon resonance (SPR) phenomenon characterized by a strong absorption band in the visible range by the interaction of the light with the unbound balance electrons of the gold, and the other physical and chemical proprieties of AuNPs has been widely characterized by TEM; SEM; Energy Dispersive X ray spectroscopy (EDX); AFM analysis; X ray diffraction (XRD); UV-vis and Fourier Transformed Infrared (FTIR) spectroscopies; Ramman-spectroscopy; and Electrophoretic Ligth Scattering (ELS) [
10].
Here, to evaluate the effect of AuNPs in enhancing the bioactive of
B. procumbens effect in tissue repair of skin injuries, and due biocompatibility and extensive investigation of AuNPs [
11,
12], we performed the synthesis and characterization of gold nanoparticles functionalized with polyphenolic compounds from
B. procumbens (AuNPs-BP); subsequently this colloidal dispersion was mixed into a hydrogel for topical administration in the rat excision wound model.
3. Discussion
Metallic nanoparticles have gained much attention as powerful materials for nanomedicine, catalysis, environmental research, biosensor, and drug delivery due their physicochemical properties [
21].
Gold nanoparticles displayed the surface plasmon resonance phenomenon, responsible of their optical proprieties, permitting to follow and easily control their size, shape and composition [
15]. On the other hand, surface modification of AuNPs provide stable matrix for biomolecular functionalization of several molecules such as proteins, organic compounds or plant extracts between others. Related to plants extracts are uses as capping agents due their phytochemical composition enrichment of flavonoids, phenols and terpenoids, similar to BP [
6,
21].
Here we conjugated the AuNPs with the bioactive of
B. procumbens polyphenolic compounds (BP) that promotes tissue repair and wound healing
6. The characterization of AuNPs synthesis and AuNP-BP conjugation were done by Uv-visible spectrophotometry, FTIR-spectra and DLS and electrophoretic light scattering to determinate their optical properties, size, concentration, agglomeration state, hints on NP shape, surface composition, ligand binding, and hydrodynamic size [
10,
22].
Conjugation of BP to AuNPs shift the nanoparticles absorbance from 520 nm to 524 nm, the resonance wavelength and band width of AuNPs are dependent on the particle size and shape [
15].
The Lambert-Beer law indicates that the absorbance is directly proportional to the extinction coefficient multiplied by the path length and the concentration of the solution. Otherwise, Mie and coworkers, demonstrated that the oscillation modes depend on the particle size and as the size decreases, the maximum absorption also decreases, events that we observed when AuNPs were conjugate with BP [
22,
23].
Higher concentrations of AuNPs-BP displayed a peak at 668 nm related to the chorophyll α; some reports have shown that higher concentrations of extracts could capping and stabilizing agents such as phenolics, flavonoids, alkaloids, polysaccharides, saponins, tannins, and organic acids, leadding Au-hydro-complex rather than nanoparticles. Thus, we chose the BP concentration of 1.6 mg/ml for the optimum capping formation [
13,
21].
According with the FTIIR analyses of BP and AuNPs-BP, peaks at 1700 cm
-1, 1610 cm
-1, 1512 cm
-1, 1450 cm
-1, 1375 cm
-1, 1258 cm
-1, 1230 cm
-1, 1171 cm
-1, 1076 cm
-1 and 1045 cm
-1 suggest that the AuNPs are capping with BP polyphenols previously reported
6, similar to other reports where polyphenols derived from alcoholic extracts natural resources capped gold nanoparticles [
16,
17].
Nanoparticle size varieties by the instrumentation method due it could change by various interaction forces in solution, including Van der Waals forces. Polyphenols limit particle growth and prevent agglomeration stabilizing the gold nanoparticles [
21]. Here we found that gold nanoparticles alone are around 9 nm by UV-Vis spectra, and change to 28 nm when are capping with BP; but when they are measured by DLS, is the initial size measured at 44.51 nm increasing to 44.58 nm, in a similar way as has been describing when the capping is performed [
21]. The increment of AuNP-BP sizes measured by the two methods suggest includes the biomolecule compounds, mainly polyphenols, enveloping the core of AuNPs, stabilized the gold nanoparticles.
The zeta potential provides valuable information about the surface charge as well as the stability of AuNPs-BP in colloidal systems [
24]. The AuNP-BP potential was -18-2 ± 7.02 mV, indicating an important stabilization; the conjugation of BP compounds increased the AuNPs stability, conferring a higher negative zeta potential. It is known that highly negative zeta potential value indicates that there is enough force to prevent the aggregation of the gold particles, considering value lower than -30 mV as strongly anionic. BP through the functional groups of polyphenols (-OH and –COOH), provide negative charge, like other studies reported [
21].
Interestingly, using an hydrogel containing AuNP-BP at 1.6 mg/ml of BP concentration for wound treatment in a wound excision animal model, we showed an enhanced percentage of wound reduction seven days posttreatment in contrast to animals treated with hydrogel containing AuNPs alone. suggesting that the capping compounds derived from BP induced these wound healing effects, as we previous describe with the BP alone [
6].
Our findings are in concordance with other reports that showed that gold nanoparticles capping with natural products, such as quercetin derived from
Abelmoschus esculentus (L.) (okra), enhanced wound healing [
25].
BP and AuNP-BP compounds not only showed a better macroscopical effects; it induced a reduction of inflammatory infiltration [
25]; increased re-epitelization and better collagen organization,
Abelmoschus esculentus (L.) (okra), AuNPs showed organized collagen fibers and blood vessels at 12 days [
25].
Histological changes suggest that at seven days the lesions are on the proliferative phase, showing the granulation tissue that involves collagen and elastin; collagen also showed better organization when injuries were treated with AuNP-BP as demonstrated by Masson and Picrosiruis Red stainings [
26].
By FTIR spectroscopy, we found a shift on collagen bandsamide I and amide II (1651 cm
-1 and 1549 cm
-1), to 1456 cm
-1, and 1240 cm
-1, respectively. Those shifts suggest conforming changes on helices, that were analyzed by the increase on ratio at 1657 cm
-1-1652 cm
-1/1689 cm
-1-1679 cm
-1, which showed an increase in AuNP-BP, demonstrating a better collagen alignment, as it was described by de Campos Vidal and Mello, 2019 [
20,
27].
Other change observed at 1082 cm
-1, is associated to symmetric phosphate stretching from nucleic acids, presented increased in the spectral data on BP and AuNP-BP suggesting an increase on cells proliferation whithin wound enhancing wound healing process [
26].
All results together suggest that nanoconjugation of biological compounds could accelerate the wounding healing process diminishing the time of tissue repair having the conformation of tissue with better physiological and mechanical proprieties and diminishing the putative adverse side effects produced by some of the bioactive compounds.
Author Contributions
Conceptualization, D.G.P.-I. and M.d.C.G.-G; methodology, A.M.-C. M.M.M-M; software, M.R.L.; validation, M.R.L., J.O.L. and R.J.D.M.; formal analysis, A.M.-C., D.G.P.-I.; M.R.L; G.J.V-Z.; investigation, A.M.-C. and M.R.L.; resources, D.G.P.-I. and M.d.C.G.-G.; writing—original draft preparation. A.M.-C. and D.G.P.-I.; writing—review and editing, A.M.-C., D.G.P.-I and M.R.L.; visualization, D.G.P.-I. and M.R.L.; supervision, D.G.P.-I., M.d.C.G.-G.; M.R.L. and R.J.D.M project administration, D.G.P.-I. and M.d.C.G.-G.; funding acquisition, D.G.P.-I. and M.d.C.G.-G. All authors have read and agreed to the published version of the manuscript.
Figure 1.
Uv-visible spectra of AuNPs, and the conjugate AuNP-BP at different concentrations of the polyphenolic compounds (BP) from B. procumbens (0.4 - 6.4 mg/mL).
Figure 1.
Uv-visible spectra of AuNPs, and the conjugate AuNP-BP at different concentrations of the polyphenolic compounds (BP) from B. procumbens (0.4 - 6.4 mg/mL).
Figure 2.
FTIR spectra of AuNPs, BP, and AuNP-BP at 1.6 mg/ml. Band frequencies marked as 1 to 14 are described in
Table 1.
Figure 2.
FTIR spectra of AuNPs, BP, and AuNP-BP at 1.6 mg/ml. Band frequencies marked as 1 to 14 are described in
Table 1.
Figure 3.
Z potential of (a) AuNPs and (b) AuNP-BP at 1.6 mg/ml.
Figure 3.
Z potential of (a) AuNPs and (b) AuNP-BP at 1.6 mg/ml.
Figure 4.
Morphometric changes induced by the different topical treatments. a. Macroscopical changes in groups at 7 days post wound healing. b. Wound reduction area between groups. *** p<0.001 and **** p <0.0001. WOT, without treatment group; AuNPs, gold nanoparticles group; BP, B. procumbes polyphenolic compounds; AuNP-BP, gold nanoparticles conjugated with BP.
Figure 4.
Morphometric changes induced by the different topical treatments. a. Macroscopical changes in groups at 7 days post wound healing. b. Wound reduction area between groups. *** p<0.001 and **** p <0.0001. WOT, without treatment group; AuNPs, gold nanoparticles group; BP, B. procumbes polyphenolic compounds; AuNP-BP, gold nanoparticles conjugated with BP.
Figure 5.
Histological changes of wounds after 7 days of treatments. Representative microphotographs of wounds stained with hematoxylin/eosin (H&E) and Masson’s trichrome in WOT, AuNPs, BP, and AuNP-BP. Inflammatory cells (black arrow); fibroblasts (red arrow); blood vessels (green arrow).
Figure 5.
Histological changes of wounds after 7 days of treatments. Representative microphotographs of wounds stained with hematoxylin/eosin (H&E) and Masson’s trichrome in WOT, AuNPs, BP, and AuNP-BP. Inflammatory cells (black arrow); fibroblasts (red arrow); blood vessels (green arrow).
Figure 6.
Collagen organization on wounds after 7 days of treatments. Representative microphotographs of Picrosirius Red staining under polarized light in normal skin, WOT, AuNPs, BP, and AuNP-BP. Greenish fibers (collagen type III) and yellow-red fibers (collagen type I). Collagen fibers (blue arrow). Bar = 100 µm.
Figure 6.
Collagen organization on wounds after 7 days of treatments. Representative microphotographs of Picrosirius Red staining under polarized light in normal skin, WOT, AuNPs, BP, and AuNP-BP. Greenish fibers (collagen type III) and yellow-red fibers (collagen type I). Collagen fibers (blue arrow). Bar = 100 µm.
Figure 7.
FTIR spectra average of WOT, AuNPs, BP, and AuNP-BP.
Figure 7.
FTIR spectra average of WOT, AuNPs, BP, and AuNP-BP.
Figure 8.
Bands with significant major peak shift. FTIR spectra of skin after 7 days of healing; without treatment (WOT), and with different treatments: AuNPs, BP, and AuNP-BP.
Figure 8.
Bands with significant major peak shift. FTIR spectra of skin after 7 days of healing; without treatment (WOT), and with different treatments: AuNPs, BP, and AuNP-BP.
Figure 9.
Bands with significant changes on absorbance. a. Bands with significant decrease between BP and AuNP-BP in comparison with WOT or AuNPs. b. bands with an increase in comparison with AuNPs. c. Bands with an increase in comparison with AuNPs.
Figure 9.
Bands with significant changes on absorbance. a. Bands with significant decrease between BP and AuNP-BP in comparison with WOT or AuNPs. b. bands with an increase in comparison with AuNPs. c. Bands with an increase in comparison with AuNPs.
Figure 10.
Negative of Second derivative FTIR spectra of Amide I. a. FTIR spectra average of negative second derivative of WOT, AuNPs, BP, and AuNP-BP. b. AUC ratio α-helix/β sheet. ** p <0.01, ****p<0.0001.
Figure 10.
Negative of Second derivative FTIR spectra of Amide I. a. FTIR spectra average of negative second derivative of WOT, AuNPs, BP, and AuNP-BP. b. AUC ratio α-helix/β sheet. ** p <0.01, ****p<0.0001.
Table 1.
FTIR band frequencies and the related functional groups observed in gold nanoparticles (AuNPs), BP and AuNP-BP conjugate.
Table 1.
FTIR band frequencies and the related functional groups observed in gold nanoparticles (AuNPs), BP and AuNP-BP conjugate.
Band |
AuNPs |
|
BP |
AuNP-BP 1.6 mg/ml |
Functional group |
Reference |
1 |
1742 |
|
- |
- |
O-H on AuNPs |
[14] |
2 |
1712 |
|
- |
- |
N-H on AuNPs |
[14] |
3 |
- |
|
1703 |
1703 |
C=O |
[16] |
4 |
1637 |
|
- |
- |
N-H on AuNPs |
[15] |
5 |
1612 |
|
1608 |
1608 |
aromatic double bond |
[16] |
6 |
1589 |
|
1589 |
1589 |
CH2-O on AuNPs |
[15] |
7 |
1512 |
|
1512 |
1510 |
C-C flavonoids and aromatic rings |
[17] |
8 |
1470 |
|
- |
- |
C-C on AuNPs |
[14] |
9 |
1402 |
|
- |
- |
C=O on AuNPs |
[15] |
10 |
- |
|
1258 |
1259 |
C-O on polyols |
[17] |
11 |
- |
|
1230 |
1229 |
C-O on polyols |
[17] |
12 |
|
|
1171 |
1165 |
C-O and –OH of primary alcohols |
[17] |
13 |
1076 |
|
1076 |
1074 |
C-O alcohols, phenols, carboxylic anions |
[14,17] |
14 |
- |
|
1045 |
1055 |
C-O and –OH of tertiary alcohols |
[17] |
Table 2.
FTIR bands assigment.
Table 2.
FTIR bands assigment.
Band |
|
Assignment |
Reference |
1 |
1737 |
C=O lipids |
[18] |
2 |
1660 |
C= O Amide I |
[18,19] |
3 |
1549 |
C-N, N-H Amide II |
[18,19] |
4 |
1456 |
CH2 lipids |
[18,19] |
5 |
1400 |
CH3 GAGs |
[19] |
6 |
1338 |
CH2 Collagen type I |
[19] |
7 |
1286 |
CH2 collagen Amide III, glycine and proline |
[19] |
8 |
1246 |
PO2- asym Phospholipds |
[18] |
9 |
1204 |
CH2 Collagen Amide III |
[19] |
10 |
1161 |
C-O carbohidrates residues |
[19] |
11 |
1085 |
PO2- sym Phospholipds, C-O of carbohydrate on Collagen and PG |
[18,19] |
Table 3.
FTIR band frequencies observed in skin at 7 day on groups without treatment (WOT), or treated with AuNPs, BP and AuNP-BP.
Table 3.
FTIR band frequencies observed in skin at 7 day on groups without treatment (WOT), or treated with AuNPs, BP and AuNP-BP.
Band |
WOT |
AuNPs |
BP |
AuNP-BP |
P |
1 |
1736 (1736, 1736) |
1736 (1736, 1736) |
1736 (1736, 1736) |
1736 (1736, 1736) |
0.069 |
2 |
1651 (1645, 1651) |
1651 (1651, 1651)a
|
1651 (1651, 1651)a
|
1651 (1651, 1651)a
|
0.016 |
3 |
1549 (1549, 1549) |
1551 (1551, 1552)a
|
1551 (1549, 1551)a
|
1551 (1549, 1551)ab
|
0.000 |
4 |
1456 (1454, 1456) |
1456 (1456, 1456) |
1456 (1454, 1656)b
|
1456 (1456, 1456.) |
0.001 |
5 |
1402 (1400, 1402) |
1402 (1402, 1402) |
1402 (1402, 1402) |
1402 (1402, 1402) |
0.317 |
6 |
1339 (1339, 1340) |
1339 (1339, 1340) |
1339 (1337, 1340) |
1340.46 (1339, 1340) |
0.713 |
7 |
1285 (1283, 1286) |
1285 (1285, 1286) |
1286 (1285, 1288) |
1285 (1285, 1286) |
0.081 |
8 |
1240 (1240, 1240) |
1240 (1240, 1242) |
1240 (1240, 1242) |
1242 (1240, 1242)ab
|
0.028 |
9 |
1207 (1207, 1211) |
1207 (1207, 1209) |
1209 (1207, 1211) |
1209 (1207, 1211) |
0.088 |
10 |
1163 (1161, 1171) |
1164 (1162, 1168) |
1163 (1163, 1171) |
1167 (1163, 1171) |
0.497 |
11 |
1082 (1082, 1082) |
1082 (1082, 1082) |
1082 (1082, 1084)ab
|
1082 (1082, 1082) |
0.000 |
Table 4.
FTIR bands absorbance observed in skin at 7 day on groups without treatment (WOT), treated with gold nanoparticles (AuNPs), BP and conjugate (AuNP-BP).
Table 4.
FTIR bands absorbance observed in skin at 7 day on groups without treatment (WOT), treated with gold nanoparticles (AuNPs), BP and conjugate (AuNP-BP).
Band |
WOT |
AuNPs |
BP |
AuNP-BP |
P |
1 |
0.4 (0.16, 0.64) |
0.19(0.12, 0.29) |
0.28 (0.23, 0.62) |
0.28 (0.23, 0.34) |
0.08 |
2 |
4.03 (3.88, 4.17) |
4.08 (4.96, 4.13) |
4.09 (4.06, 4.2) |
4.07 (4.03, 4.1) |
0.128 |
3 |
4.36 (4.33, 4.45) |
4.21 (4.19, 4.24)a
|
4.35 (4.24, 4.45)b
|
4.28 (4.24, 4.33)ab
|
0.0001 |
4 |
1.58 (1.52, 1.74) |
1.51 (1.47, 1.54) |
1.55 (1.51, 1.61)b
|
1.53 (1.49, 1.55)a
|
0.012 |
5 |
1.64 (1.55, 1.66) |
1.56 (1.53, 1.58)a
|
1.63 (1.58, 1.74)b
|
1.63 (1.56, 1.67) b
|
0.001 |
6 |
1.06 (1.01, 1.13) |
1.06 (1.03, 1.08) |
1.09 (1.04, 1.15) |
1.06 (1.05, 1.08) |
0.305 |
7 |
1.06 (1, 1.12) |
1.01 (0.98, 1.04)a
|
1.07 (0.99, 1.17) b
|
1.02 (1.02, 1.04) |
0.04 |
8 |
1.36 (1.28, 1.44) |
1.3 (1.23, 1.34) |
1.36 (1.25, 1.48) |
1.28 (1.26, 1.33) |
0.091 |
9 |
0.89 (0.84, 0.99) |
0.85 (0.81, 0.89)a
|
0.93 (0.84, 1.02) b
|
0.89 (0.86, 0.93) b
|
0.015 |
10 |
0.76 (0.72, 0.87) |
0.66 (0.63, 0.72)a
|
0.79 (0.69, 0.92) b
|
0.75 (0.69, 0.81) b
|
0.003 |
11 |
1.14 (0.99, 1.22) |
1.11 (1.07, 1.17) |
1.19 (1.13, 1.35)ab
|
1.2 (1.16, 1.23) b
|
0.003 |